BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35430567)

  • 1. Effects of GSK-J4 on JMJD3 Histone Demethylase in Mouse Prostate Cancer Xenografts.
    Sanchez A; Penault-Llorca F; Bignon YJ; Guy L; Bernard-Gallon D
    Cancer Genomics Proteomics; 2022; 19(3):339-349. PubMed ID: 35430567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
    Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H3K27me3 demethylases regulate in vitro chondrogenesis and chondrocyte activity in osteoarthritis.
    Yapp C; Carr AJ; Price A; Oppermann U; Snelling SJ
    Arthritis Res Ther; 2016 Jul; 18(1):158. PubMed ID: 27388528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSK-J4: An H3K27 histone demethylase inhibitor, as a potential anti-cancer agent.
    Dalpatraj N; Naik A; Thakur N
    Int J Cancer; 2023 Sep; 153(6):1130-1138. PubMed ID: 37165737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histone demethylase inhibitor GSK-J4 limits inflammation through the induction of a tolerogenic phenotype on DCs.
    Doñas C; Carrasco M; Fritz M; Prado C; Tejón G; Osorio-Barrios F; Manríquez V; Reyes P; Pacheco R; Bono MR; Loyola A; Rosemblatt M
    J Autoimmun; 2016 Dec; 75():105-117. PubMed ID: 27528513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jumonji domain containing-3 (JMJD3) inhibition attenuates IL-1β-induced chondrocytes damage in vitro and protects osteoarthritis cartilage in vivo.
    Jun Z; Xinmeng J; Yue L; Zhi W; Yan Z; Tieyi Y; Jiangan T
    Inflamm Res; 2020 Jul; 69(7):657-666. PubMed ID: 32394143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low HOX gene expression in PML-RARα-positive leukemia results from suppressed histone demethylation.
    Rejlova K; Musilova A; Kramarzova KS; Zaliova M; Fiser K; Alberich-Jorda M; Trka J; Starkova J
    Epigenetics; 2018; 13(1):73-84. PubMed ID: 29224413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone demethylase JMJD3 regulates fibroblast-like synoviocyte-mediated proliferation and joint destruction in rheumatoid arthritis.
    Jia W; Wu W; Yang D; Xiao C; Su Z; Huang Z; Li Z; Qin M; Huang M; Liu S; Long F; Mao J; Liu X; Zhu YZ
    FASEB J; 2018 Jul; 32(7):4031-4042. PubMed ID: 29481307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevating H3K27me3 level sensitizes colorectal cancer to oxaliplatin.
    Wang Q; Chen X; Jiang Y; Liu S; Liu H; Sun X; Zhang H; Liu Z; Tao Y; Li C; Hu Y; Liu D; Ye D; Liu Y; Wang M; Zhang X
    J Mol Cell Biol; 2020 Feb; 12(2):125-137. PubMed ID: 31065671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.
    Jiang Y; Xiang C; Zhong F; Zhang Y; Wang L; Zhao Y; Wang J; Ding C; Jin L; He F; Wang H
    Theranostics; 2021; 11(1):361-378. PubMed ID: 33391480
    [No Abstract]   [Full Text] [Related]  

  • 11. EZH2, JMJD3, and UTX epigenetically regulate hepatic plasticity inducing retro-differentiation and proliferation of liver cells.
    Pediconi N; Salerno D; Lupacchini L; Angrisani A; Peruzzi G; De Smaele E; Levrero M; Belloni L
    Cell Death Dis; 2019 Jul; 10(7):518. PubMed ID: 31285428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of JMJD3 Demethylase and Its Inhibitor GSK-J4 in Regulation of
    Sanchez A; El Ouardi D; Houfaf Khoufaf FZ; Idrissou M; Boisnier T; Penault-Llorca F; Bignon YJ; Guy L; Bernard-Gallon D
    OMICS; 2020 Aug; 24(8):505-507. PubMed ID: 32525734
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of H3K27me3 Demethylases Promotes Plasmablast Formation.
    Kania AK; Guo M; Scharer CD; Boss JM
    Immunohorizons; 2021 Dec; 5(12):918-930. PubMed ID: 34880105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antischistosomal potential of GSK-J4, an H3K27 demethylase inhibitor: insights from molecular modeling, transcriptomics and in vitro assays.
    Lobo-Silva J; Cabral FJ; Amaral MS; Miyasato PA; de Freitas RP; Pereira ASA; Khouri MI; Barbosa MMF; Ramos PIP; Leite LCC; Asojo OA; Nakano E; Verjovski-Almeida S; Farias LP
    Parasit Vectors; 2020 Mar; 13(1):140. PubMed ID: 32178714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystathionine-γ-lyase ameliorates the histone demethylase JMJD3-mediated autoimmune response in rheumatoid arthritis.
    Wu W; Qin M; Jia W; Huang Z; Li Z; Yang D; Huang M; Xiao C; Long F; Mao J; Moore PK; Liu X; Zhu YZ
    Cell Mol Immunol; 2019 Aug; 16(8):694-705. PubMed ID: 29844591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone demethylase Jmjd3 modulates osteoblast apoptosis induced by tumor necrosis factor-alpha through directly targeting RASSF5.
    Sun HY; Yang D; Mi J; Yu YQ; Qiu LH
    Connect Tissue Res; 2020 Nov; 61(6):517-525. PubMed ID: 31092054
    [No Abstract]   [Full Text] [Related]  

  • 17. A new metabolic gene signature in prostate cancer regulated by JMJD3 and EZH2.
    Daures M; Idrissou M; Judes G; Rifaï K; Penault-Llorca F; Bignon YJ; Guy L; Bernard-Gallon D
    Oncotarget; 2018 May; 9(34):23413-23425. PubMed ID: 29805743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomic Profiling and H3K27me3 Distribution Reveal Both Demethylase-Dependent and Independent Regulation of Developmental Gene Transcription in Cell Differentiation.
    Kang SC; Kim SK; Chai JC; Kim SH; Won KJ; Lee YS; Jung KH; Chai YG
    PLoS One; 2015; 10(8):e0135276. PubMed ID: 26263556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutically targeting head and neck squamous cell carcinoma through synergistic inhibition of LSD1 and JMJD3 by TCP and GSK-J1.
    Zhang W; Cheng J; Diao P; Wang D; Zhang W; Jiang H; Wang Y
    Br J Cancer; 2020 Feb; 122(4):528-538. PubMed ID: 31848446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma.
    Lochmann TL; Powell KM; Ham J; Floros KV; Heisey DAR; Kurupi RIJ; Calbert ML; Ghotra MS; Greninger P; Dozmorov M; Gowda M; Souers AJ; Reynolds CP; Benes CH; Faber AC
    Sci Transl Med; 2018 May; 10(441):. PubMed ID: 29769286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.